What is the price target for INTT stock?
9 analysts have analysed INTT and the average price target is 18.02 USD. This implies a price increase of 0.9% is expected in the next year compared to the current price of 17.86.
NYSEARCA:INTT • US4611471008
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTEST CORP (INTT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Lake Street | Maintains | Buy -> Buy |
| 2025-05-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-01-08 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2025-01-02 | Northland Capital Markets | Upgrade | Market Perform -> Outperform |
| 2024-11-04 | Northland Capital Markets | Maintains | Market Perform -> Market Perform |
| 2024-08-05 | Northland Capital Markets | Downgrade | Outperform -> Market Perform |
| 2024-05-07 | Lake Street | Maintains | Buy -> Buy |
| 2023-06-26 | EF Hutton | Maintains | Buy -> Buy |
| 2023-06-08 | Northland Capital Markets | Maintains | Outperform |
| 2023-05-05 | EF Hutton | Maintains | Buy |
| 2023-03-08 | EF Hutton | Initiate | Buy |
| 2022-11-21 | Northland Capital Markets | Initiate | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 123.302M 5.54% | 130.69M 5.99% | 113.825M -12.90% | 131.83M 15.82% | 143.83M 9.10% | 151.75M 5.51% | 162.07M 6.80% | |
| EBITDA YoY % growth | 15.122M -2.15% | 8.786M -41.90% | 3.921M -55.37% | 10.182M 159.68% | 11.814M 16.03% | N/A | N/A | |
| EBIT YoY % growth | 10.439M -2.63% | 3.394M -67.49% | -2.875M -184.71% | 3.337M 216.07% | 5.589M 67.49% | 9.212M 64.82% | 11.631M 26.26% | |
| Operating Margin | 8.47% | 2.60% | -2.53% | 2.53% | 3.89% | 6.07% | 7.18% | |
| EPS YoY % growth | 1.01 2.02% | 0.51 -49.50% | 0.06 -88.24% | 0.41 588.50% | 0.53 28.40% | 0.74 40.38% | 0.91 21.92% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 180.37% | 0.10 228.68% | 0.11 644.02% | 0.13 -19.25% | 0.12 38.46% | 0.16 65.51% | 0.20 82.81% | 0.23 77.63% |
| Revenue Q2Q % growth | 32.33M 21.37% | 32.625M 15.98% | 33.201M 26.55% | 33.679M 2.61% | 36.72M 13.58% | 37.026M 13.49% | 37.434M 12.75% | 37.944M 12.66% |
| EBITDA Q2Q % growth | 2.301M 378.23% | 2.336M -9.98% | 2.682M -31.79% | 2.864M -65.40% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 443.19K 117.26% | 654.33K 192.03% | 988.89K 191.82% | 1.251M -15.53% | N/A | N/A | N/A | N/A |
All data in USD
9 analysts have analysed INTT and the average price target is 18.02 USD. This implies a price increase of 0.9% is expected in the next year compared to the current price of 17.86.
INTEST CORP (INTT) will report earnings on 2026-05-01.
The consensus EPS estimate for the next earnings of INTEST CORP (INTT) is 0.09 USD and the consensus revenue estimate is 32.33M USD.
The number of analysts covering INTEST CORP (INTT) is 9.